Skip to main content

December 2015

 

 

academics

 

Clinical research courses

Work at IHBT for various research projects | Walk in

Govt. of Himachal Pradesh took up initiative in early seventies to set up a CSIR lab to make prudential use of the natural resources of the region.

Career as Regional Managers / Area Managers at Feron Healthcare

We are from Feron healthcare(P) Ltd, INDIA, the introduction is as follows: Feron Health Care is a privately owned, very young Indian specialty bio-pharma company with operations in market development of innovative bio-pharmaceuticals. This Organization has Directors, who have been extraordinarily successful in the Bio-pharmaceuticals business in India in the past.

Psychiatric symptoms such as depression, mania, hallucinations, anxiety disorders and anorexia nervosa, even without any neurological signs, may be signs of a brain tumour, according to doctors who treated a woman thought to have treatment-resistant depression.

Opening in production for ITI operator - Easy Reach Management Consultants

Easy Reach Placement, Established  is a excellent brand equity with a premium image amongst HR community at many Indian Giants and Blue chip Multinational Conglomerates in catering manpower placement services for our valued patrons to manage their Human Assets. In the era of Hi-tech Millennium & Rapid Globalization with prevailing competition, sourcing of Right Candidate for the Right Job at Right Time at Right Cost. Easy reach is making significant Contribution in terms of meeting our Valued Clients quality manpower requirements ranging from Junior Level to Corporate Heads.

Opportunity for GM - HR for requirement of MR at Pharma Company - Easy Reach Management Consultants

specialized in senior and middle level placement

Post: GM-HR

The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion recommending approval of Astrazeneca's Brilique (ticagrelor) 60mg for the treatment of patients with a history of heart attack and at high risk of having a further atherothrombotic event. The opinion states that, treatment may be started as continuation therapy after an initial one-year treatment with dual anti platelet therapy.

(adsbygoogle = window.adsbygoogle || []).push({});